gr 144053 has been researched along with Carotid Artery Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H; Ito, T; Kozawa, O; Matsuno, H; Nishida, M; Niwa, M; Tanabe, K; Uematsu, T | 1 |
| Collen, D; Kozawa, O; Matsuno, H; Matsuo, O; Uematsu, T; Ueshima, S | 1 |
2 other study(ies) available for gr 144053 and Carotid Artery Thrombosis
| Article | Year |
|---|---|
Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster.
Topics: Animals; Bleeding Time; Carotid Artery Thrombosis; Cell Division; Cricetinae; Disease Models, Animal; Drug Interactions; Fibrinogen; Fibrinolytic Agents; Male; Muscle, Smooth; Peptides; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1998 |
Lack of tPA significantly affects antithrombotic therapy by a GPIIb/IIIa antagonist, but not by a thrombin inhibitor in mice.
Topics: Animals; Arginine; Bleeding Time; Carotid Artery Thrombosis; Dose-Response Relationship, Drug; Fibrinolytic Agents; Mice; Mice, Knockout; Pipecolic Acids; Piperazines; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2000 |